海角破解版

NU7441

NHEJ pathway inhibitor; Inhibits DNA-dependent protein kinase (DNA-PK)

NU7441

NHEJ pathway inhibitor; Inhibits DNA-dependent protein kinase (DNA-PK)

Catalog #
(Select a product)
NHEJ pathway inhibitor; Inhibits DNA-dependent protein kinase (DNA-PK)
Request Pricing Request Pricing

Overview

NU7441 is an inhibitor of DNA-dependent protein kinase (DNA-PK), an enzyme involved in the non-homologous end joining (NHEJ) DNA repair pathway. It is highly selective for DNA-PK, with an IC鈧呪個 of 14 nM (Leahy et al.).

GENOME EDITING
路Reduces the frequency of NHEJ and increases the efficiency of homology-directed repair (HDR) in CRISPR-Cas9 genome editing (Robert et al.).

CANCER RESEARCH
路 Sensitizes human cancer cell lines to DNA double-strand-break-inducing therapies (chemo- or radio-therapy) by inhibiting DNA-PK activity and delaying the repair of double-strand breaks (Ciszewski et al.; Shaheen et al.; Yang et al.; Zhao et al.).
Cell Type
Cancer Cells and Cell Lines, Prostate Cells
Species
Human, Mouse, Non-Human Primate, Other, Rat
Application
Genome Editing
Area of Interest
Cancer
CAS Number
503468-95-9
Chemical Formula
颁鈧傗倕贬鈧佲倝狈翱鈧侨
Purity
鈮 98%

Protocols and Documentation

Find supporting information and directions for use in the Product Information Sheet or explore additional protocols below.

Document Type
Product Name
Catalog #
Lot #
Language
Document Type
Product Name
Catalog #
74082, 74084
Lot #
All
Language
English
Document Type
Product Name
Catalog #
74082, 74084
Lot #
All
Language
English

Applications

This product is designed for use in the following research area(s) as part of the highlighted workflow stage(s). Explore these workflows to learn more about the other products we offer to support each research area.

Resources and Publications

Publications (1)

DNA damage in macrophages drives immune autoreactivity via nuclear antigen presentation G. Niotis et al. Nature Aging 2026 Jan

Abstract

Aging and DNA damage increase the risk of chronic inflammation and autoimmunity, yet the molecular underpinnings remain unclear. In this study, we uncover a DNA damage-driven mechanism in macrophages that triggers immune autoreactivity. Here, using Er1Lyz2/鈭 mice with a macrophage-specific DNA repair defect in ERCC1鈭扻PF, we demonstrate that monocyte-derived macrophages accumulate DNA damage, activate the immune system, drive polyclonal T cell responses and generate antinuclear autoantibodies. Proteomic and immunopeptidomic analyses reveal a distinct major histocompatibility complex class II (MHC-II) antigen repertoire enriched in nuclear and ribosomal peptides, relying on autophagy for nuclear cargo delivery to MHC-II. Aged macrophages exhibit a similar lysosomal cargo profile, linking autophagy-driven nuclear antigen presentation to immune activation. Notably, inhibiting autophagy in Er1Lyz2/鈭 mice suppresses autoimmune features, pinpointing autophagy-facilitated nuclear antigen processing as a central driver of age-related autoimmunity. These findings establish DNA damage-induced autophagy in macrophages as a pivotal mechanism linking aging to autoimmunity, unveiling potential therapeutic targets to mitigate age-related immune dysregulation. Using a mouse model with a macrophage-specific DNA repair defect, Niotis, Arvanitaki et al. identify DNA damage-induced autophagy in macrophages as a link from aging to autoimmunity.